Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Emily Program is a leading healthcare provider specializing in the treatment of eating disorders, offering a comprehensive continuum of care for individuals of all ages and genders. Founded in 1993, the organization provides residential, partial hospitalization, intensive outpatient, and outpatient services across multiple states, including Minnesota, Ohio, Pennsylvania, and Washington. Their multidisciplinary approach integrates medical, nutritional, and psychological care to address conditions such as anorexia nervosa, bulimia nervosa, and binge eating disorder. In 2021, The Emily Program merged with Veritas Collaborative to form Accanto Health, significantly expanding its clinical expertise and geographic reach. The program is widely recognized for its evidence-based treatment models and commitment to personalized recovery journeys.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Emily Program.